Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma 18Hodgkin Disease 11Lymphoma, Non-Hodgkin 4Central Nervous System Neoplasms 4Recurrence 3Glioblastoma 3Astrocytoma 3Oligodendroglioma 2Neurotoxicity Syndromes 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Lymphoma, AIDS-Related 2Radiation Injuries 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Intraocular Lymphoma 1HIV Infections 1Gliosarcoma 1Glioma 1Burkitt Lymphoma 1Brain Neoplasms 1

Interventions

Cyclophosphamide 64Peripheral Blood Stem Cell Transplantation 48Etoposide 40Filgrastim 34Rituximab 33Radiotherapy 33fludarabine phosphate 30Busulfan 28Mycophenolic Acid 27Tacrolimus 24Cyclosporine 24Cytarabine 23Antilymphocyte Serum 22Whole-Body Irradiation 21Methotrexate 21Melphalan 21Carmustine 16sargramostim 15Methylprednisolone 15Vincristine 12Prednisone 12Cisplatin 12Doxorubicin 9Dexamethasone 9Cord Blood Stem Cell Transplantation 9Ifosfamide 8Granulocyte Colony-Stimulating Factor 7etoposide phosphate 6Sirolimus 6Carboplatin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Lymphoma, Large-Cell, Immunoblastic × Procarbazine × Clear all
NCT00003113 2011-01-17

Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas

Case Comprehensive Cancer Center

Phase 2 Terminated
6 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡